{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":29,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":29,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"13fea598a257","filters":{"venue":"Drug development & registration"}},"results":[{"id":"W4281633450","doi":"10.33380/2305-2066-2022-11-2-180-186","title":"Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Antibody; Medicine; Virology; Immunoglobulin G; Drug; Polyclonal antibodies; Antiviral drug; Coronavirus disease 2019 (COVID-19); Immunology; Pharmacology; Infectious disease (medical specialty); Disease; Internal medicine","authors":[{"name":"T. I. Smolyanova","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true},{"name":"М. А. Колганова","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"А. М. Николаева","is_ca":false},{"name":"T. V. Vyaznikova","is_ca":false},{"name":"A. A. Pankratova","is_ca":false},{"name":"E. A. Bykova","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07213643085207633,"gpt":0.3924006549297945,"spread":0.3202642240777182,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169448,0.001143316,0.0009246203,0.0002899689,0.000265418,0.0008000562,0.0005776145,0.000893015,0.002712304],"category_scores_gemma":[0.0005750021,0.0004544004,0.0007131787,0.0002207703,0.0005455192,0.0004277327,0.0001727133,0.002056263,0.0007797297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008110316,"about_ca_system_score_gemma":0.001531349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006678107,"about_ca_topic_score_gemma":0.0007460094,"domain_scores_codex":[0.9997007,0.0001045987,0.000008957706,0.00007526299,0.00004070345,0.00006977371],"domain_scores_gemma":[0.9996738,0.00004101964,0.0000648951,0.00004191901,0.00004929187,0.0001289704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3760144,0.1068903,0.007492187,0.000958881,0.001259075,0.0004042512,0.0003890587,0.006084933,0.3660979,0.001534048,0.01210443,0.1207705],"study_design_scores_gemma":[0.1059623,0.7547513,0.0162325,0.0000682738,0.0008259992,0.0009650667,0.0001012088,0.004689618,0.08683127,0.0006174094,0.02888612,0.00006899747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816371,0.003096042,0.004505148,0.0004472807,0.0003207812,0.003657399,0.002324681,0.0003161072,0.003695475],"genre_scores_gemma":[0.9796593,0.002002128,0.003144627,0.0009955578,0.0001752213,0.002545551,0.003424088,0.00009962506,0.007953939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002712304,"threshold_uncertainty_score":0.009073555,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3130804109","doi":"10.33380/2305-2066-2021-10-1-83-89","title":"Isolation of Individual Compounds from the Terrestrial Parts of Ononis Arvensis L. and Solidago Canadensis L.","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Medicinal plant effects and applications","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Saint petersburg; Traditional medicine; Botany; Solidago canadensis; Biology; Isolation (microbiology); Chemistry; Invasive species","authors":[{"name":"В. Г. Лужанин","is_ca":false},{"name":"A. K. Whaley","is_ca":false},{"name":"A. O. Ponkratova","is_ca":false},{"name":"E. A. Grishukova","is_ca":false},{"name":"Ivan Sergeevich Suloev","is_ca":false},{"name":"С. Н. Смирнов","is_ca":false},{"name":"Evgeny B. Serebryakov","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02710027645694021,"gpt":0.2626046924800863,"spread":0.2355044160231461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000851799,0.001088979,0.0004854845,0.002063958,0.0004447756,0.0003236641,0.000223388,0.0003010612,0.002118883],"category_scores_gemma":[0.0001850958,0.000154868,0.0005214712,0.00111491,0.0002850656,0.0003478634,0.0003239052,0.0006004557,0.0007102764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380604,"about_ca_system_score_gemma":0.0004047918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001584406,"about_ca_topic_score_gemma":0.00282814,"domain_scores_codex":[0.999891,0.00001177937,0.000008272561,0.00003229921,0.00003693998,0.00001964277],"domain_scores_gemma":[0.9998664,0.00002913425,0.0000204908,0.00001437507,0.00003583205,0.00003377348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003818343,0.0002209837,0.002265393,0.001068925,0.0001076795,0.0009391377,0.0002066451,0.0002121472,0.9437905,0.0002474159,0.0004592047,0.05010024],"study_design_scores_gemma":[0.0003678427,0.004641413,0.2107999,0.0006686171,0.001279649,0.006588205,0.00133467,0.001188057,0.6030338,0.001815759,0.1681435,0.0001385647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8723786,0.06723773,0.01549796,0.0007232013,0.0004418786,0.0009532712,0.008212583,0.000376736,0.03417794],"genre_scores_gemma":[0.9329146,0.02354663,0.01652707,0.0007243592,0.0002374643,0.0004337352,0.0139051,0.0000765843,0.01163461],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002118883,"threshold_uncertainty_score":0.007088363,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294681241","doi":"10.33380/2305-2066-2022-11-3-220-229","title":"Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; High-performance liquid chromatography; Chemistry; Pharmacokinetics; Protein precipitation; Therapeutic drug monitoring; Formic acid; Pharmacology; Medicine; Coronavirus disease 2019 (COVID-19)","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"P. K. Karnakova","is_ca":true},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"K. Ya. Zaslavskaya","is_ca":false},{"name":"P. A. Bely","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03748672329783132,"gpt":0.3383106008460899,"spread":0.3008238775482586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003294003,0.001556123,0.0009740991,0.002030152,0.001108523,0.0009737845,0.001176992,0.002812181,0.002145209],"category_scores_gemma":[0.003969846,0.001002086,0.001068622,0.0009263346,0.0009570536,0.0006964722,0.0007580402,0.001410494,0.002413215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008585124,"about_ca_system_score_gemma":0.002379253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001791824,"about_ca_topic_score_gemma":0.002494739,"domain_scores_codex":[0.9945999,0.001371022,0.0003775275,0.00144786,0.002002802,0.000200894],"domain_scores_gemma":[0.9984083,0.000522865,0.0002172437,0.0001257558,0.0006341244,0.00009178979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005613454,0.0004415528,0.004499749,0.001593514,0.0002249455,0.0003439049,0.0002966399,0.001002526,0.9188322,0.0007747054,0.001543075,0.06988586],"study_design_scores_gemma":[0.0003186136,0.003372828,0.02141498,0.0006042611,0.000501728,0.007015533,0.0003042428,0.01214332,0.9134366,0.000975686,0.03966456,0.0002476673],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.2243955,0.0587705,0.6857169,0.00136834,0.001399982,0.003440813,0.00318981,0.006934902,0.0147833],"genre_scores_gemma":[0.3970432,0.01553626,0.5673631,0.002271346,0.0003528119,0.004333179,0.003214475,0.0003586775,0.009526995],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.003294003,"threshold_uncertainty_score":0.01742059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4213452411","doi":"10.33380/2305-2066-2022-11-1-140-147","title":"Pharmacokinetics Study of the Long-acting Antiarrhythmic Drug of Lappaconitine Hydrobromide (Allaforte®, JSC \"Pharmcenter VILAR\", Russia)","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Cmax; Pharmacology; Drug; Plasma concentration; Alkaloid; Chemistry; Medicine; Stereochemistry","authors":[{"name":"O. A. Archakova","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"Т. Н. Комаров","is_ca":false},{"name":"A. V. Rogov","is_ca":false},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"A. V. Suvorova","is_ca":true},{"name":"P. K. Karnakova","is_ca":false},{"name":"P. A. Karpova","is_ca":false},{"name":"I. E. Shohin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08764112469374505,"gpt":0.4045696862444642,"spread":0.3169285615507191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001781272,0.0001639645,0.0002275822,0.0001011108,0.00006349215,0.0001496773,0.0001013289,0.000128352,0.001244229],"category_scores_gemma":[0.0002895725,0.0001150833,0.000187405,0.00009912729,0.00009279946,0.0001273047,0.00006780897,0.0002766362,0.0002392426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000149117,"about_ca_system_score_gemma":0.0002147511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005747221,"about_ca_topic_score_gemma":0.0005421343,"domain_scores_codex":[0.9998766,0.00003649889,0.000006992145,0.00003377711,0.00003160885,0.00001450251],"domain_scores_gemma":[0.999927,0.00001900595,0.00001945058,0.000008035261,0.00001165471,0.00001474466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.007939968,0.0004717146,0.009855983,0.0003467531,0.0002367514,0.0002808786,0.0001460657,0.001925693,0.8882974,0.000374027,0.0009583629,0.0891664],"study_design_scores_gemma":[0.001310364,0.03986814,0.1992122,0.0000781017,0.0005255824,0.005807486,0.0001584855,0.02041918,0.6992712,0.0005390433,0.0327097,0.000100544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799812,0.008679801,0.007765489,0.0001554877,0.00004050472,0.00009432748,0.0005713435,0.0001507878,0.002560942],"genre_scores_gemma":[0.9935915,0.001861308,0.002451572,0.00007080873,0.00001488375,0.00004104095,0.0004230157,0.00001916603,0.001526679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001244229,"threshold_uncertainty_score":0.004162312,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3031640402","doi":"10.33380/2305-2066-2020-9-2-145-150","title":"Method of Estimating the Equivalence of Dissolution Profiles: a Modern View (Review)","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Mahalanobis distance; Outlier; Similarity (geometry); Equivalence (formal languages); Dissolution; Statistics; Mathematics; Weibull distribution; Comparability; Dissolution testing; Sample (material); Computer science; Econometrics; Combinatorics; Chemistry; Chromatography; Artificial intelligence; Discrete mathematics","authors":[{"name":"I. E. Shohin","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true},{"name":"Е. А. Малашенко","is_ca":false},{"name":"V. N. Kuzina","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1660472766000856,"gpt":0.4344404072342946,"spread":0.2683931306342091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002888482,0.00123435,0.003638278,0.006083392,0.0002663108,0.001852674,0.001930101,0.001657683,0.003603772],"category_scores_gemma":[0.005879496,0.0007219844,0.001779239,0.005892188,0.001280263,0.002275405,0.0008857116,0.002274823,0.002128917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001368113,"about_ca_system_score_gemma":0.001756833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002529694,"about_ca_topic_score_gemma":0.001569131,"domain_scores_codex":[0.9980373,0.0004746819,0.0002534589,0.0003501401,0.0008271474,0.00005742734],"domain_scores_gemma":[0.9971322,0.001606339,0.0004520693,0.00008975887,0.0006615284,0.00005809234],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000973137,0.00005687805,0.0005265713,0.04911288,0.0005243084,0.0001573284,0.00006224674,0.0008855762,0.0008013354,0.007367505,0.01753269,0.9228753],"study_design_scores_gemma":[0.00005976438,0.0004245516,0.007767252,0.01572256,0.001205156,0.003106565,0.0001195186,0.001312311,0.001364024,0.00890832,0.9598571,0.0001529189],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009730313,0.9971395,0.001680829,0.0002694719,0.0001954912,0.00002065595,0.00006799833,0.00001401249,0.0005147551],"genre_scores_gemma":[0.002025797,0.9938468,0.002993509,0.0002376756,0.000263031,0.00005737994,0.0001186001,0.0000067389,0.0004505116],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006083392,"threshold_uncertainty_score":0.01527596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008140779","doi":"10.33380/2305-2066-2020-9-1-99-108","title":"Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Atazanavir; Ritonavir; Pharmacokinetics; Chromatography; Human plasma; Protein precipitation; Therapeutic drug monitoring; Chemistry; Pharmacology; Human immunodeficiency virus (HIV); Medicine; Antiretroviral therapy; Viral load; Virology","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"I. E. Shohin","is_ca":false},{"name":"O. A. Miskiv","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"Yu. V. Medvedev","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02505392348828441,"gpt":0.2949525593858599,"spread":0.2698986358975755,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002222857,0.0012021,0.0007458332,0.001639741,0.000819109,0.0007067723,0.0009359457,0.001781378,0.001572172],"category_scores_gemma":[0.002819176,0.0005631077,0.0008219285,0.0007240287,0.0006687954,0.0005386894,0.0005992445,0.001004754,0.001522005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005228883,"about_ca_system_score_gemma":0.002118807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008880393,"about_ca_topic_score_gemma":0.001378686,"domain_scores_codex":[0.9953734,0.0009501443,0.0003925654,0.0009350983,0.002206866,0.0001419357],"domain_scores_gemma":[0.9988569,0.0002935932,0.0001804556,0.0001005838,0.0005197259,0.00004859643],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003627617,0.0004026972,0.003743631,0.0008462719,0.0001680709,0.0003318471,0.0002279542,0.0009954512,0.9238783,0.0009772052,0.0008280351,0.06723787],"study_design_scores_gemma":[0.0001165068,0.001753679,0.008358074,0.0001912916,0.0001902346,0.002464471,0.0001308348,0.00816974,0.9567934,0.0006189879,0.0210971,0.0001156915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.3285726,0.02363051,0.6200702,0.001018621,0.0008881928,0.003684889,0.003177651,0.003734214,0.01522319],"genre_scores_gemma":[0.4263023,0.00977718,0.5456595,0.001281125,0.0002330528,0.003758064,0.002769044,0.0001701829,0.01004958],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002222857,"threshold_uncertainty_score":0.0117557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129249197","doi":"10.33380/2305-2066-2021-10-1-120-128","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Chromatography; High-performance liquid chromatography; Protein precipitation; Chemistry; Pharmacokinetics; Detection limit; Active metabolite; Metabolite; Human cytomegalovirus; Pharmacology; Medicine; Biochemistry","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"M. A. Tokareva","is_ca":false},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"V. V. Davydanova","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204984643737607,"gpt":0.3349398710299538,"spread":0.3028900245925777,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307777,0.001315149,0.0007827086,0.001536208,0.0006701183,0.0007883087,0.0006959451,0.001935935,0.001327975],"category_scores_gemma":[0.002861276,0.0005578574,0.0007424385,0.0006462024,0.0008328013,0.0004716231,0.0006076791,0.001177451,0.001077543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007750527,"about_ca_system_score_gemma":0.002172267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001595977,"about_ca_topic_score_gemma":0.001788452,"domain_scores_codex":[0.9946516,0.001192865,0.0003922843,0.001079574,0.002497033,0.0001867932],"domain_scores_gemma":[0.99906,0.0002209504,0.0001505745,0.000080842,0.0004349228,0.00005280187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006563878,0.0002701358,0.006138016,0.001048429,0.0001929576,0.000337667,0.0001680962,0.000916538,0.9209265,0.0006829168,0.0009162435,0.06774598],"study_design_scores_gemma":[0.0001601701,0.00184851,0.01177475,0.0002510824,0.00024718,0.002947461,0.0001116233,0.007917961,0.9542064,0.0006258473,0.01978498,0.000123971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.3599156,0.05902737,0.552233,0.00155753,0.001272155,0.004155275,0.004745052,0.003448264,0.01364567],"genre_scores_gemma":[0.6129004,0.01487195,0.35526,0.001928808,0.0002878926,0.003605756,0.002750138,0.0001786329,0.008216378],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.003307777,"threshold_uncertainty_score":0.01749337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3132138449","doi":"10.33380/2305-2066-2021-10-1-31-36","title":"PD-L1 as a Potential Target in Cancer Therapy (Review)","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Durvalumab; Avelumab; Immunotherapy; Immune system; Cancer; Medicine; Clinical trial; Cancer immunotherapy; Mechanism (biology); Immunology; Cancer research; Internal medicine; Nivolumab","authors":[{"name":"N. N. Andrusova","is_ca":false},{"name":"М. А. Колганова","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"I. E. Shohin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01983293940426857,"gpt":0.3036877309930628,"spread":0.2838547915887942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003368657,0.0007589184,0.001088703,0.001331264,0.0002501221,0.001147422,0.0007385066,0.0009487696,0.006539631],"category_scores_gemma":[0.0005530548,0.000178044,0.0008002788,0.00130907,0.0002378874,0.0009595878,0.0004645094,0.001716874,0.001764314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006314854,"about_ca_system_score_gemma":0.001208326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008590839,"about_ca_topic_score_gemma":0.001468478,"domain_scores_codex":[0.9998241,0.00002934021,0.00002512331,0.00003617605,0.00006389731,0.00002140878],"domain_scores_gemma":[0.9997826,0.00007352878,0.0000457966,0.000005459629,0.00007305181,0.00001956455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001191727,0.00005787882,0.0001189418,0.03370581,0.0001479464,0.0001361413,0.00003626039,0.0004127736,0.001044256,0.001919592,0.07928044,0.8830209],"study_design_scores_gemma":[0.00003711502,0.0001372297,0.0006406329,0.008088239,0.0002688336,0.001046126,0.00003968523,0.000113577,0.000385755,0.001154149,0.9880704,0.00001834824],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001311179,0.9979091,0.0001063846,0.0004335492,0.0005101539,0.00001078594,0.00004959569,0.0000100452,0.0008391099],"genre_scores_gemma":[0.001035508,0.9970207,0.0001627763,0.0004860378,0.0003553001,0.00001565804,0.000097251,0.000001710471,0.0008250638],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006539631,"threshold_uncertainty_score":0.02187729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4322752875","doi":"10.33380/2305-2066-2023-12-1-215-226","title":"Simultaneous Determination of Major Molnupiravir Metabolite (β-D-N4-hydroxycytidine) and Favipiravir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Favipiravir; Chromatography; Chemistry; High-performance liquid chromatography; Formic acid; Ammonium formate; Electrospray ionization; Tandem mass spectrometry; Selected reaction monitoring; Triethylamine; Mass spectrometry; Medicine; Coronavirus disease 2019 (COVID-19)","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"P. K. Karnakova","is_ca":true},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"K. Ya. Zaslavskaya","is_ca":false},{"name":"P. A. Bely","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01459622847467556,"gpt":0.2870625750746341,"spread":0.2724663465999585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006522329,0.0008139694,0.0004105524,0.0008499419,0.0004849827,0.0004328231,0.0003871656,0.00103371,0.0009394819],"category_scores_gemma":[0.0007841181,0.0003558468,0.0003232435,0.0004151784,0.0003440757,0.0002550502,0.0002940026,0.0004674383,0.0005831948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003893581,"about_ca_system_score_gemma":0.0008400833,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001370615,"about_ca_topic_score_gemma":0.001941754,"domain_scores_codex":[0.999047,0.0001806271,0.00006580538,0.0003363354,0.000312392,0.00005775718],"domain_scores_gemma":[0.999739,0.0000678821,0.00005714448,0.00001521681,0.00009371483,0.00002710047],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007252096,0.0001251745,0.005211654,0.0004232277,0.0001377166,0.0003091281,0.0001125102,0.0004435428,0.9654655,0.0001604653,0.0004480104,0.02643777],"study_design_scores_gemma":[0.0001447416,0.001703523,0.02552221,0.0001075675,0.0002333204,0.005006707,0.0001573389,0.009740351,0.9459707,0.0003451397,0.01097569,0.00009258628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8022027,0.03505086,0.1437643,0.0006297467,0.0004192296,0.001055495,0.003747834,0.002777567,0.01035231],"genre_scores_gemma":[0.8843524,0.007135021,0.1010219,0.0009180597,0.00009758892,0.0008113303,0.001651073,0.00009187656,0.003920657],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001370615,"threshold_uncertainty_score":0.00344938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3198549098","doi":"10.33380/2305-2066-2021-10-3-105-113","title":"Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Alkaloid; Chemistry; Chromatography; Diterpene; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Metabolite; Aconitum; Quantitative analysis (chemistry); Active metabolite; Pharmacology; Stereochemistry; Biochemistry; Medicine","authors":[{"name":"O. A. Archakova","is_ca":true},{"name":"Т. Н. Комаров","is_ca":false},{"name":"A. V. Rogov","is_ca":false},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"I. E. Shohin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05625091011436616,"gpt":0.3656614644053199,"spread":0.3094105542909537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000230991,0.0003528929,0.0001455146,0.000407693,0.0001866791,0.0001607972,0.0001770341,0.0004282411,0.0008155746],"category_scores_gemma":[0.0004017983,0.0001201332,0.0001438489,0.0002321826,0.0001924964,0.0001860125,0.0001276379,0.0002554895,0.0002624334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001919343,"about_ca_system_score_gemma":0.00031905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009323615,"about_ca_topic_score_gemma":0.001603444,"domain_scores_codex":[0.9997105,0.00004255618,0.00002000508,0.0000882142,0.0001239366,0.00001471928],"domain_scores_gemma":[0.999863,0.00002998813,0.00003601044,0.00001103922,0.00004276925,0.00001716967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003542811,0.00004747128,0.004086015,0.0002067359,0.00003122469,0.0001604686,0.00005238111,0.0001280688,0.9739213,0.00009657303,0.0001567139,0.02075875],"study_design_scores_gemma":[0.00004069984,0.0009021728,0.02376184,0.00003765714,0.00006874,0.00228936,0.00005955275,0.002415414,0.9647653,0.0001207401,0.005517252,0.00002122523],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9143855,0.02126124,0.05632461,0.0003463926,0.0001296625,0.0002993371,0.00165366,0.0006047102,0.004994846],"genre_scores_gemma":[0.9510792,0.005332041,0.03685499,0.0003121914,0.00004422983,0.0002536041,0.001228243,0.00002527013,0.004870226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009323615,"threshold_uncertainty_score":0.002728343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3197910357","doi":"10.33380/2305-2066-2021-10-3-55-69","title":"Development of a Gastro-retentive Dosage Form of a New Promising Anti-tuberculosis Drug Macozinone","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bioavailability; Mucoadhesion; Drug; Dosage form; Pharmacology; Tuberculosis; Lipophilicity; Active ingredient; Chemistry; Medicine; Drug carrier; Stereochemistry","authors":[{"name":"В. Г. Нестеренко","is_ca":false},{"name":"Р. Н. Болгарин","is_ca":false},{"name":"B. A. Rudoy","is_ca":false},{"name":"Salakhetdinov D.K.","is_ca":false},{"name":"Yu. G. Kazaishvili","is_ca":false},{"name":"V. S. Scherbakova","is_ca":false},{"name":"N. A. Nikitina","is_ca":false},{"name":"Yu. V. Medvedev","is_ca":true},{"name":"Е. Н. Фишер","is_ca":false},{"name":"Е. А. Малашенко","is_ca":false},{"name":"I. E. Shohin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08563882169745975,"gpt":0.3943502260694476,"spread":0.3087114043719879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001653548,0.0002661455,0.000273742,0.0003054895,0.00009722159,0.00025318,0.0002442489,0.0003062688,0.00139186],"category_scores_gemma":[0.0002433976,0.0001313096,0.000261638,0.0001337601,0.000164921,0.00029324,0.0001398281,0.0003102045,0.0003358485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001634803,"about_ca_system_score_gemma":0.0001897058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003743386,"about_ca_topic_score_gemma":0.0006144915,"domain_scores_codex":[0.9998851,0.00001464576,0.00001151585,0.0000279959,0.00005071705,0.000009985054],"domain_scores_gemma":[0.9999243,0.00001084094,0.0000282465,0.000006946563,0.00001588137,0.00001378073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001785952,0.00006042067,0.0001350339,0.0002686407,0.00001329228,0.00008051299,0.00002333451,0.0001130441,0.9864396,0.0001517918,0.00008495646,0.01245074],"study_design_scores_gemma":[0.0001485422,0.002556401,0.003400778,0.00003203642,0.00006774659,0.0005313827,0.00002401169,0.000992924,0.975657,0.00002916808,0.01654194,0.00001812775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9631287,0.01087177,0.01944114,0.0002630975,0.0001241168,0.0007782603,0.0008300261,0.0001965074,0.004366426],"genre_scores_gemma":[0.9513215,0.005883313,0.03732529,0.0000916627,0.00003406778,0.0002035141,0.0006487402,0.00003485081,0.00445704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00139186,"threshold_uncertainty_score":0.004656255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3109322209","doi":"10.33380/2305-2066-2020-9-4-146-154","title":"Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pomalidomide; Protein precipitation; Chromatography; High-performance liquid chromatography; Detection limit; Multiple myeloma; Chemistry; Pharmacokinetics; Thalidomide; Pharmacology; Medicine; Internal medicine","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"M. A. Tokareva","is_ca":false},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"V. V. Davydanova","is_ca":true},{"name":"Н. П. Садчикова","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06006610392576663,"gpt":0.3667722658832706,"spread":0.3067061619575039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002061013,0.00148817,0.0007894472,0.002075454,0.001201197,0.0009166674,0.0008409162,0.001790711,0.002997268],"category_scores_gemma":[0.002874996,0.0005803555,0.0007429376,0.0008353183,0.0008609807,0.000627299,0.0006932499,0.001272118,0.00200885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009403608,"about_ca_system_score_gemma":0.002897574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001994363,"about_ca_topic_score_gemma":0.003113537,"domain_scores_codex":[0.9953561,0.0007040668,0.000334071,0.001226993,0.002204802,0.0001739179],"domain_scores_gemma":[0.9991758,0.0001653775,0.0001506657,0.00007057722,0.0003870183,0.00005045571],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007394188,0.0004391815,0.007214039,0.001229799,0.0002536844,0.0004902803,0.0003165388,0.001244853,0.9126866,0.001533563,0.002811346,0.07104062],"study_design_scores_gemma":[0.0001407299,0.001040322,0.007940341,0.0002273758,0.0002272906,0.00231376,0.0001857246,0.008551076,0.9395871,0.0008409477,0.03879792,0.0001475091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.272743,0.03752948,0.6404178,0.001564108,0.001450954,0.006230669,0.007512909,0.006102796,0.02644824],"genre_scores_gemma":[0.4170518,0.01471324,0.5361709,0.002825691,0.0003549499,0.005356112,0.005415518,0.00034923,0.0177625],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.002997268,"threshold_uncertainty_score":0.01089978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3217188055","doi":"10.33380/2305-2066-2021-10-4-177-189","title":"Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Candesartan; Hydrochlorothiazide; Chromatography; Chemistry; Valsartan; High-performance liquid chromatography; Indapamide; Formic acid; Angiotensin II; Pharmacology; Diuretic; Medicine; Internal medicine; Blood pressure","authors":[{"name":"P. K. Karnakova","is_ca":false},{"name":"Т. Н. Комаров","is_ca":true},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"P. A. Karpova","is_ca":false},{"name":"I. E. Shohin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02195911776104404,"gpt":0.3242124255106955,"spread":0.3022533077496514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001833739,0.001169547,0.0009705149,0.001544503,0.0006941381,0.0006858423,0.0006096189,0.001868394,0.001742071],"category_scores_gemma":[0.001810478,0.0004978915,0.0005561485,0.0008650108,0.0006506444,0.0005142667,0.0005009801,0.0008046961,0.001202188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005630495,"about_ca_system_score_gemma":0.001383346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001022971,"about_ca_topic_score_gemma":0.001628949,"domain_scores_codex":[0.9971879,0.0004490369,0.0001762752,0.0009238417,0.001138358,0.0001245744],"domain_scores_gemma":[0.9993474,0.0002213827,0.0001217176,0.00004837138,0.0002123827,0.00004871757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001039719,0.0002159366,0.004616049,0.0008736566,0.0003270928,0.0003232553,0.0001019362,0.0004415006,0.9330543,0.0003022553,0.001878574,0.05682568],"study_design_scores_gemma":[0.0003856482,0.002121493,0.02756255,0.0001865218,0.0005348383,0.005399615,0.0001396115,0.01071682,0.9326657,0.0007194201,0.01940394,0.0001637947],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.5846048,0.06993838,0.3059806,0.001991355,0.001475756,0.002124285,0.008885457,0.007739829,0.01725953],"genre_scores_gemma":[0.6821345,0.01705064,0.2804987,0.003534519,0.000595267,0.002526549,0.003758474,0.0002869038,0.009614501],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.001868394,"threshold_uncertainty_score":0.009697855,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3217107789","doi":"10.33380/2305-2066-2020-9-2-133-139","title":"Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Valganciclovir; Ganciclovir; Prodrug; Active metabolite; Protein precipitation; High-performance liquid chromatography; Pharmacokinetics; Metabolite; Chromatography; Human cytomegalovirus; Chemistry; Pharmacology; Biology; Biochemistry","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"O. A. Miskiv","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"Yu. V. Medvedev","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04124204494144324,"gpt":0.3327477137431953,"spread":0.291505668801752,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00374196,0.001411688,0.0007988471,0.001677003,0.0009099512,0.0009729489,0.001004001,0.002137882,0.001633552],"category_scores_gemma":[0.004279466,0.00072897,0.000899773,0.0008602471,0.0009383928,0.0006735736,0.0007246258,0.001454029,0.001512334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007982418,"about_ca_system_score_gemma":0.002651879,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001693627,"about_ca_topic_score_gemma":0.002240642,"domain_scores_codex":[0.9937083,0.00153091,0.0004374042,0.001378453,0.002696406,0.0002486227],"domain_scores_gemma":[0.9986222,0.0003962682,0.0002019692,0.000131455,0.0005764056,0.00007161783],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005752247,0.0005201621,0.005707648,0.00118734,0.0001870836,0.0002714346,0.000384679,0.001257198,0.9137549,0.001189169,0.001234113,0.07373114],"study_design_scores_gemma":[0.0001142602,0.001710454,0.006668841,0.0002188247,0.0001914415,0.00190309,0.000177404,0.006371196,0.9618155,0.0005607884,0.02015556,0.0001124806],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.2855773,0.03238806,0.6540424,0.001403382,0.001099859,0.00354532,0.003153709,0.004424931,0.01436494],"genre_scores_gemma":[0.4593022,0.01155959,0.5090531,0.001642507,0.0002399475,0.003930117,0.002881218,0.0002668359,0.01112449],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.00374196,"threshold_uncertainty_score":0.01978964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3030930859","doi":"10.33380/2305-2066-2020-9-2-140-144","title":"Immunogenicity Assessment of Pegfilgrastim in Patients with Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pegfilgrastim; Medicine; Filgrastim; Immunogenicity; Neutropenia; Immunoassay; Internal medicine; Breast cancer; Cancer; Oncology; Antibody; Immunology; Chemotherapy","authors":[{"name":"Yu. V. Medvedev","is_ca":false},{"name":"М. А. Колганова","is_ca":true},{"name":"O. A. Sas","is_ca":true},{"name":"Т. Н. Комаров","is_ca":true},{"name":"Е. Н. Фишер","is_ca":false},{"name":"I. E. Shohin","is_ca":false},{"name":"Yu. I. Ammour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01122452560432387,"gpt":0.265162422345945,"spread":0.2539378967416211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005804001,0.0001757828,0.000193458,0.0002489456,0.0001283242,0.0002193028,0.00009364815,0.0002342178,0.0007351598],"category_scores_gemma":[0.000968023,0.00007350542,0.0002100789,0.0001690841,0.0001161677,0.00009260287,0.0001049196,0.0002351313,0.0001805432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001790648,"about_ca_system_score_gemma":0.0001571438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002210926,"about_ca_topic_score_gemma":0.0002489611,"domain_scores_codex":[0.9996754,0.0001273971,0.00003099101,0.00004476669,0.00008552943,0.00003586947],"domain_scores_gemma":[0.9996388,0.00008257427,0.0001483284,0.00001896714,0.00006787595,0.00004338836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009402382,0.001297854,0.8751127,0.0004631823,0.000178902,0.0006687585,0.0004061131,0.0004161897,0.03755371,0.0001081401,0.001283033,0.07310899],"study_design_scores_gemma":[0.0003053421,0.01576837,0.9461856,0.00006525608,0.0002536875,0.004935511,0.0002201907,0.001205548,0.02498361,0.0000989172,0.005960871,0.00001716857],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971181,0.001382475,0.000303534,0.00007058006,0.00001861663,0.0000678206,0.0001187088,0.00001110652,0.0009091138],"genre_scores_gemma":[0.9987183,0.0003022288,0.0003225236,0.00008199381,0.00001717145,0.00004774626,0.0001638842,0.000001091777,0.0003450893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007351598,"threshold_uncertainty_score":0.00306946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3172267348","doi":"10.33380/2305-2066-2021-10-2-87-99","title":"HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Cholecalciferol; Vitamin D and neurology; Vitamin; Chromatography; High-performance liquid chromatography; Chemistry; Extraction (chemistry); Medicine; Biochemistry; Internal medicine","authors":[{"name":"I. E. Shohin","is_ca":true},{"name":"Е. А. Малашенко","is_ca":false},{"name":"Yu. V. Medvedev","is_ca":false},{"name":"M N Bogachuk","is_ca":false},{"name":"С. А. Кулаков","is_ca":false},{"name":"M.A. Paleeva","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04060706993902249,"gpt":0.3446414756800197,"spread":0.3040344057409973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003716122,0.001427118,0.0009085308,0.002269246,0.001399961,0.0007803005,0.001002105,0.001475926,0.003386363],"category_scores_gemma":[0.004051795,0.0008100758,0.0009672462,0.001134615,0.001017977,0.0007066473,0.0008300102,0.001267544,0.003331148],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001206012,"about_ca_system_score_gemma":0.004533237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003730171,"about_ca_topic_score_gemma":0.004836582,"domain_scores_codex":[0.9932954,0.001707762,0.0005137666,0.001163153,0.003081278,0.0002386755],"domain_scores_gemma":[0.9977432,0.0005544075,0.0003018402,0.0002309256,0.001078016,0.00009151475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003432875,0.0004301116,0.00434013,0.001554643,0.0001849344,0.0002774706,0.0001995421,0.001367664,0.8877075,0.001602621,0.002402795,0.09958921],"study_design_scores_gemma":[0.00009862544,0.001208838,0.01003893,0.0003021483,0.0002211606,0.00177486,0.0001300196,0.006600596,0.9327969,0.0005796185,0.04612638,0.0001218338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.1473762,0.02114013,0.7987875,0.000667796,0.0007937887,0.004468139,0.0031521,0.004600218,0.01901411],"genre_scores_gemma":[0.3120283,0.01176261,0.650262,0.001089499,0.0002108384,0.006243479,0.003477128,0.0004087416,0.01451744],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.003730171,"threshold_uncertainty_score":0.01965296,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2989685308","doi":"10.33380/2305-2066-2019-8-4-61-74","title":"Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmacological Effects and Assays","field":"Agricultural and Biological Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ambroxol; Chromatography; Chemistry; Salbutamol; Pharmacokinetics; Bioequivalence; High-performance liquid chromatography; Solid phase extraction; Pharmacology; Medicine; Anesthesia; Asthma","authors":[{"name":"Т. Н. Комаров","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"O. A. Miskiv","is_ca":true},{"name":"A. V. Aleshina","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"Yu. V. Medvedev","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true},{"name":"I. M. Korenskaya","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01669685533173103,"gpt":0.2668592125995313,"spread":0.2501623572678002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001476688,0.0008347947,0.0004988123,0.001026395,0.000535304,0.0005106027,0.0004277389,0.001411106,0.001283359],"category_scores_gemma":[0.001867699,0.0003358598,0.0006070266,0.0003946567,0.0005560672,0.0003304717,0.0003920496,0.0005593901,0.0008498094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004318822,"about_ca_system_score_gemma":0.001404874,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007918816,"about_ca_topic_score_gemma":0.00109717,"domain_scores_codex":[0.997219,0.0005019276,0.000223423,0.0005174146,0.001446406,0.0000919135],"domain_scores_gemma":[0.9994017,0.0001562262,0.0001196114,0.0000391012,0.0002448476,0.00003853936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005079355,0.0002293416,0.002798568,0.0006080486,0.00009524723,0.0002554728,0.0001297515,0.0003778781,0.9603475,0.0002649531,0.0003265066,0.03405872],"study_design_scores_gemma":[0.0001291301,0.002045964,0.01231437,0.0001694477,0.0001790788,0.00254323,0.000110133,0.003993399,0.9677674,0.0002916763,0.01039328,0.00006283751],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.6516067,0.03377249,0.2968487,0.00126949,0.0007415143,0.002971513,0.002814517,0.00174888,0.008226171],"genre_scores_gemma":[0.739899,0.01122582,0.2345076,0.001467945,0.0002814446,0.002852475,0.001844405,0.0000896892,0.007831718],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.001476688,"threshold_uncertainty_score":0.007809579,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2991632468","doi":"10.33380/2305-2066-2019-8-4-53-60","title":"Chemical and Toxicological Analysis of Antiretroviral Drugs","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Efavirenz; Nevirapine; Atazanavir; Ritonavir; Darunavir; Abacavir; Zidovudine; Medicine; Pharmacology; Lamivudine; Lopinavir; Urine; Human immunodeficiency virus (HIV); Virology; Internal medicine; Viral load; Antiretroviral therapy; Viral disease; Virus","authors":[{"name":"T. N. Komarov","is_ca":true},{"name":"М. В. Белова","is_ca":false},{"name":"D. D. Stolyarova","is_ca":false},{"name":"I. E. Shohin","is_ca":true},{"name":"D. S. Bogdanova","is_ca":true},{"name":"O. A. Miskiv","is_ca":true},{"name":"Yu. V. Medvedev","is_ca":false},{"name":"I. M. Korenskaya","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009202233969733001,"gpt":0.2486848659693983,"spread":0.2394826319996654,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007808365,0.0006989088,0.0003685605,0.00300562,0.0007089296,0.0006731812,0.0004862781,0.0007408225,0.004638441],"category_scores_gemma":[0.001143171,0.0002389836,0.000783067,0.001122214,0.0004058645,0.0004824281,0.0005187807,0.0006630196,0.001507436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005593395,"about_ca_system_score_gemma":0.001089805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001723272,"about_ca_topic_score_gemma":0.00229045,"domain_scores_codex":[0.9980981,0.000264639,0.0001191957,0.0003198848,0.001085265,0.0001129566],"domain_scores_gemma":[0.999279,0.0001257921,0.0001666835,0.0000487036,0.0003314129,0.00004844488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004227713,0.0004247771,0.05280218,0.002974588,0.0005001719,0.001632073,0.0003107222,0.001748038,0.7042549,0.003977397,0.00706053,0.2238918],"study_design_scores_gemma":[0.00005418167,0.001373128,0.0764095,0.0006241933,0.0003734321,0.007781179,0.0004376394,0.006923992,0.720556,0.003751727,0.1815618,0.0001532436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5481181,0.1674401,0.1339339,0.003044643,0.002538706,0.001595761,0.02166255,0.001941391,0.1197248],"genre_scores_gemma":[0.8220979,0.04712277,0.08172373,0.002312416,0.0005749598,0.0007799567,0.008588078,0.0001545932,0.03664558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004638441,"threshold_uncertainty_score":0.01551712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3169402917","doi":"10.33380/2305-2066-2021-10-2-120-127","title":"Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method","year":2021,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Blood transfusion and management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tranexamic acid; Chromatography; High-performance liquid chromatography; Protein precipitation; Pharmacokinetics; Chemistry; Calibration curve; Bioequivalence; Selected reaction monitoring; Tandem mass spectrometry; Detection limit; Mass spectrometry; Pharmacology; Medicine; Blood loss; Surgery","authors":[{"name":"A. V. Aleshina","is_ca":true},{"name":"Т. Н. Комаров","is_ca":false},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"V. V. Davydanova","is_ca":true},{"name":"А. Yu. Savchenko","is_ca":false},{"name":"I. E. Shohin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02098583117285222,"gpt":0.2869589802017825,"spread":0.2659731490289302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003049154,0.00146036,0.0009830981,0.001593088,0.001079307,0.0007923514,0.0007547767,0.001844985,0.002621032],"category_scores_gemma":[0.003606174,0.0005760437,0.0007673512,0.000869369,0.0009345195,0.0007130933,0.0007809805,0.001073537,0.001758006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007329597,"about_ca_system_score_gemma":0.002930865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001319243,"about_ca_topic_score_gemma":0.001719696,"domain_scores_codex":[0.9944253,0.001170457,0.0005019431,0.001163909,0.002547658,0.0001907688],"domain_scores_gemma":[0.998601,0.0002574704,0.000267084,0.0001076896,0.0007005798,0.00006616444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007184933,0.0003691024,0.004752394,0.001246713,0.0002057064,0.0004576947,0.0002257627,0.0007500246,0.9109322,0.001084905,0.001309873,0.0779473],"study_design_scores_gemma":[0.0001889369,0.002221891,0.01173648,0.0002609824,0.0003085735,0.003846166,0.0001423938,0.007395284,0.9443725,0.0006260028,0.02874521,0.00015554],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.3483019,0.03922951,0.5771936,0.00147894,0.001447281,0.00568395,0.004932738,0.00380274,0.01792929],"genre_scores_gemma":[0.5139732,0.01601685,0.4440179,0.002165101,0.0003643559,0.006512576,0.0036827,0.0002369094,0.01303034],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.003049154,"threshold_uncertainty_score":0.01612562,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388760934","doi":"10.33380/2305-2066-2023-12-4-1467","title":"Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Granulation; Anhydrous; Citric acid; Compaction; Raw material; Pulp and paper industry; Materials science; Chemical engineering; Chemistry; Food science; Composite material; Engineering; Organic chemistry","authors":[{"name":"G. V. Trusov","is_ca":false},{"name":"Б. В. Бровченко","is_ca":false},{"name":"Z. M. Kozlova","is_ca":false},{"name":"I. I. Krasnyuk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1266812609583558,"gpt":0.4118216122839858,"spread":0.28514035132563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009371967,0.0009921564,0.0005758387,0.001328246,0.0005358753,0.0009371673,0.0005865241,0.001062772,0.008269826],"category_scores_gemma":[0.002021526,0.0003783393,0.000753294,0.0007093172,0.0004325606,0.0006082379,0.0006161635,0.0004956042,0.003832982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004981105,"about_ca_system_score_gemma":0.001103417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009789543,"about_ca_topic_score_gemma":0.002206633,"domain_scores_codex":[0.9983155,0.0001788883,0.0002980285,0.0001867922,0.0009230798,0.00009786187],"domain_scores_gemma":[0.9986981,0.0002694831,0.00036101,0.0001017429,0.0004962423,0.00007343851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003425695,0.00009991957,0.0008088197,0.001077494,0.00001197286,0.0007163296,0.0001509598,0.0006248822,0.9679055,0.001773914,0.000759006,0.02572875],"study_design_scores_gemma":[0.000166072,0.002925276,0.0132286,0.0004143377,0.0001345439,0.002282783,0.0001966628,0.003791239,0.8942543,0.0006094298,0.08193567,0.0000610869],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.543407,0.01961181,0.3080735,0.001164227,0.0006621109,0.01639191,0.004592455,0.001372983,0.104724],"genre_scores_gemma":[0.5634493,0.01069655,0.3925706,0.0002980032,0.0001348476,0.007968917,0.004177499,0.0003176969,0.02038656],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.008269826,"threshold_uncertainty_score":0.02766532,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379276111","doi":"10.33380/2305-2066-2023-12-2-135-145","title":"Simultaneous Determination of Nirmatrelvir and Ritonavir in Human Plasma by HPLC-MS/MS","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Ritonavir; Chromatography; Chemistry; Protein precipitation; Formic acid; Electrospray ionization; High-performance liquid chromatography; Tandem mass spectrometry; Mass spectrometry; Medicine; Viral load; Virology; Virus","authors":[{"name":"Т. Н. Комаров","is_ca":false},{"name":"P. K. Karnakova","is_ca":true},{"name":"O. A. Archakova","is_ca":true},{"name":"D. S. Shchelgacheva","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"K. Ya. Zaslavskaya","is_ca":false},{"name":"P. A. Bely","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02423040301041898,"gpt":0.3254793025341892,"spread":0.3012488995237702,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00143154,0.001177544,0.0006819483,0.00137103,0.000574287,0.0006247831,0.000609352,0.001495779,0.001743131],"category_scores_gemma":[0.001487577,0.0004961506,0.0005042297,0.000729454,0.0004251305,0.0005378954,0.0004611542,0.0007298746,0.001256697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004104573,"about_ca_system_score_gemma":0.0009057183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000454788,"about_ca_topic_score_gemma":0.0007836381,"domain_scores_codex":[0.9979581,0.0004568816,0.0001531192,0.0006480686,0.0006850219,0.00009891035],"domain_scores_gemma":[0.9995263,0.0001364235,0.0001080042,0.00003793208,0.0001583213,0.00003311343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001288746,0.0003420276,0.006816818,0.0009487981,0.0003016973,0.0005683741,0.0001944291,0.0007809291,0.917483,0.0006068877,0.001844681,0.06882372],"study_design_scores_gemma":[0.0002465597,0.002390116,0.02335071,0.0002024133,0.0003937406,0.007028808,0.000179793,0.01461851,0.9214531,0.001103104,0.02886065,0.0001725432],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.6110187,0.06195539,0.2884845,0.001358396,0.001028964,0.001799097,0.008652894,0.007030434,0.01867156],"genre_scores_gemma":[0.7375529,0.01451869,0.2302968,0.002215245,0.000316541,0.002071936,0.004529668,0.0002346501,0.00826354],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.001743131,"threshold_uncertainty_score":0.007570803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313415459","doi":"10.33380/2305-2066-2022-11-4(1)-120-127","title":"Development and Validation of the ELISA Method for Anti-trastuzumab Antibodies Determination in Human Serum","year":2022,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Antibody; Medicine; Monoclonal antibody; Immunogenicity; Pharmacology; Internal medicine; Immunology; Cancer; Breast cancer","authors":[{"name":"O. A. Eliseeva","is_ca":false},{"name":"М. А. Колганова","is_ca":true},{"name":"И. Е. Шохин","is_ca":true},{"name":"S. P. Dementyev","is_ca":false},{"name":"А. М. Власов","is_ca":false},{"name":"Andrey A. Zamyatnin","is_ca":false},{"name":"N. S. Dubovik","is_ca":false},{"name":"А. Yu. Savchenko","is_ca":false},{"name":"Н. В. Дозморова","is_ca":false},{"name":"В. Г. Лужанин","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03726134688828332,"gpt":0.3462890550167478,"spread":0.3090277081284645,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826002,0.0009018605,0.0005667544,0.001477194,0.0003832474,0.0006715344,0.0008762567,0.001330976,0.001309149],"category_scores_gemma":[0.00381118,0.0004551105,0.0006612098,0.0005824155,0.0005647783,0.0004285414,0.0005440709,0.00107504,0.001521934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004703715,"about_ca_system_score_gemma":0.001133621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006729692,"about_ca_topic_score_gemma":0.001087698,"domain_scores_codex":[0.9934169,0.001483886,0.0003211667,0.0009304746,0.003666115,0.0001815369],"domain_scores_gemma":[0.9980445,0.0003788124,0.0002508805,0.0001652955,0.001080885,0.00007955714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002029858,0.0003126197,0.0030805,0.000513401,0.00005746094,0.0002036856,0.0001286387,0.0005685262,0.9445779,0.0007213233,0.0007158202,0.04891716],"study_design_scores_gemma":[0.00003802902,0.0008105685,0.006237047,0.0001146039,0.00007732591,0.001438002,0.0000555873,0.006912129,0.9690514,0.0002625567,0.01495517,0.00004766747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.2021874,0.01320416,0.7657727,0.0007719189,0.0008096019,0.001876603,0.001254385,0.002323296,0.0117999],"genre_scores_gemma":[0.4508065,0.007357792,0.5215979,0.001029912,0.0002398334,0.002159444,0.002205656,0.0001465938,0.01445623],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.002826002,"threshold_uncertainty_score":0.01494551,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947580881","doi":"10.33380/2305-2066-2019-8-2-108-114","title":"Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Tadalafil; Protein precipitation; Chromatography; Calibration curve; Chemistry; Pharmacokinetics; High-performance liquid chromatography; Detection limit; Quantitative analysis (chemistry); Extraction (chemistry); Matrix (chemical analysis); Bioequivalence; Analyte; Erectile dysfunction; Pharmacology; Medicine","authors":[{"name":"D. S. Bogdanova","is_ca":true},{"name":"T. N. Komarov","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"E. S. Melnikov","is_ca":false},{"name":"O. A. Miskiv","is_ca":true},{"name":"Yu. V. Medvedev","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04108518812559655,"gpt":0.3573362804977999,"spread":0.3162510923722033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004166966,0.001372791,0.0009474457,0.001754825,0.001251095,0.001070773,0.0008890193,0.002102709,0.002522041],"category_scores_gemma":[0.004640925,0.0007425599,0.0008577126,0.0009503505,0.000974833,0.0006693747,0.000692416,0.001273148,0.002151045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007800778,"about_ca_system_score_gemma":0.003369538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001480748,"about_ca_topic_score_gemma":0.002047303,"domain_scores_codex":[0.9923593,0.001793343,0.0006168796,0.001520283,0.003470127,0.0002399711],"domain_scores_gemma":[0.9981641,0.0004388819,0.0002422913,0.0001262724,0.0009670095,0.00006144268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008033378,0.0006779582,0.007470706,0.001781524,0.0003084098,0.0003553524,0.0004529331,0.001114593,0.8833815,0.002091049,0.002439512,0.09912307],"study_design_scores_gemma":[0.0002819794,0.003003759,0.01831993,0.0003996674,0.0005214954,0.003038633,0.0002187939,0.01342822,0.9094439,0.001063334,0.05007867,0.000201577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2349453,0.03537998,0.6937179,0.001687233,0.001643915,0.005464647,0.004615931,0.004164572,0.01838047],"genre_scores_gemma":[0.4400318,0.01564455,0.5155435,0.002478979,0.0004989159,0.006825849,0.004432664,0.0002549745,0.01428876],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.004166966,"threshold_uncertainty_score":0.02203727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2911230576","doi":"10.33380/2305-2066-2019-8-1-113-117","title":"CERTIFICATION OF QUALITY MANAGEMENT SYSTEM OF LLC «CENTER OF PHARMACEUTICAL ANALYTICS» ACCORDING TO THE REQUIREMENTS OF ISO 9001:2015 (GOST R ISO 9001-2015) (REVIEW)","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Economic, Social, and Public Health Issues in Russia and Globally","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Certification; Quality management system; Audit; Accreditation; Quality audit; Certificate; Quality assurance; Business; Management system; Conformity assessment; Quality management; Engineering management; Accounting; Computer science; Operations management; Engineering; Medicine; Service (business); Management","authors":[{"name":"А. А. Крылатова","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"E. P. Obrazcova","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1793563772042008,"gpt":0.4620114582879459,"spread":0.2826550810837452,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004731063,0.0005959098,0.001013853,0.004871188,0.0004063129,0.001513064,0.001241842,0.001262997,0.005895732],"category_scores_gemma":[0.009889236,0.0002934089,0.001012777,0.003869963,0.0008439365,0.002052939,0.0007913434,0.00128678,0.001980265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001745824,"about_ca_system_score_gemma":0.008482504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005300391,"about_ca_topic_score_gemma":0.006376881,"domain_scores_codex":[0.9948144,0.0007878891,0.0009562607,0.0004868625,0.002772095,0.0001824686],"domain_scores_gemma":[0.9907369,0.002206683,0.002363046,0.0001835224,0.004302589,0.0002073118],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009198641,0.00006761734,0.001491775,0.06753052,0.0002018259,0.0001198886,0.0001453968,0.0002240476,0.001176456,0.003765558,0.08143066,0.8437544],"study_design_scores_gemma":[0.00004896032,0.0003173775,0.01005329,0.04495054,0.0003525075,0.001158326,0.0002055609,0.0001484625,0.001342842,0.00100101,0.9403767,0.00004433475],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.0005690205,0.9919991,0.0005950327,0.00172754,0.0006332143,0.000128546,0.0002675188,0.00002756426,0.0040525],"genre_scores_gemma":[0.01146489,0.9828857,0.001098297,0.001405801,0.0004464488,0.0001736908,0.0008247498,0.00001324588,0.00168721],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.005895732,"threshold_uncertainty_score":0.02502054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379276081","doi":"10.33380/2305-2066-2023-12-2-146-153","title":"Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC \"PROMOMED RUS\", Russia)","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Pharmacokinetics; Pharmacology; Drug; Medicine; Favipiravir; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease","authors":[{"name":"Т. Н. Комаров","is_ca":false},{"name":"N. S. Bagaevа","is_ca":true},{"name":"K. K. Karnakova","is_ca":true},{"name":"I. E. Shohin","is_ca":true},{"name":"K. Ya. Zaslavskaya","is_ca":false},{"name":"P. A. Bely","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1664712180694004,"gpt":0.4490068162313977,"spread":0.2825355981619972,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000703559,0.0009417013,0.0009098913,0.0002618823,0.0003117188,0.0005313392,0.0005285423,0.0006605132,0.002778702],"category_scores_gemma":[0.0004563122,0.0004429788,0.0006852144,0.0002309207,0.0004337946,0.0004022831,0.0002073834,0.001391007,0.001005814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004645005,"about_ca_system_score_gemma":0.001179482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004677445,"about_ca_topic_score_gemma":0.0006081582,"domain_scores_codex":[0.9995891,0.0001536239,0.00001577605,0.0001095021,0.00007092935,0.00006111402],"domain_scores_gemma":[0.9998091,0.00002477123,0.00004415528,0.00003009435,0.00003187035,0.00006011564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2286219,0.03851314,0.004931172,0.001254971,0.0008250221,0.0002774246,0.0003813354,0.003674962,0.565324,0.001136797,0.008236168,0.1468231],"study_design_scores_gemma":[0.07778823,0.6100774,0.0279811,0.0001415491,0.001017302,0.002239667,0.0001288382,0.005959515,0.2272876,0.0005781527,0.04665701,0.0001436],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9708754,0.004654942,0.0106697,0.0004001018,0.0002821177,0.005255166,0.002497726,0.0007138574,0.004650871],"genre_scores_gemma":[0.966458,0.003217717,0.01062785,0.000794841,0.0001527997,0.004375188,0.004884234,0.0001514342,0.009337976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002778702,"threshold_uncertainty_score":0.009295702,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2972024183","doi":"10.33380/2305-2066-2019-8-3-79-84","title":"Development and Validation of HPLC-MS/MS Method for Busereline Quantitation in Animal Blood Plasma","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Protein precipitation; Chromatography; High-performance liquid chromatography; Chemistry; Sample preparation; Pharmacokinetics; Extraction (chemistry); Pharmacology; Medicine","authors":[{"name":"Е. Н. Фишер","is_ca":false},{"name":"E. S. Melnikov","is_ca":false},{"name":"I. E. Shohin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03168130250184206,"gpt":0.3088721256624127,"spread":0.2771908231605706,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001848349,0.0009669754,0.0006370756,0.001147657,0.0005529551,0.0005604139,0.000581203,0.001477088,0.001381619],"category_scores_gemma":[0.001992417,0.0004406279,0.0006565927,0.0005601816,0.0005909131,0.000490874,0.0003556318,0.0008673444,0.001199027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006030136,"about_ca_system_score_gemma":0.001180777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001211678,"about_ca_topic_score_gemma":0.002044576,"domain_scores_codex":[0.9979401,0.0003931624,0.0001136694,0.000588923,0.0008518994,0.0001122835],"domain_scores_gemma":[0.9991467,0.0001696572,0.0001955505,0.00005365702,0.0003815188,0.0000529477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003723129,0.0001089532,0.003088032,0.0004954313,0.0001072267,0.0001940601,0.00009460487,0.0003802402,0.9754878,0.0002363711,0.0005961132,0.01883883],"study_design_scores_gemma":[0.00007078677,0.001922373,0.01246274,0.0001385393,0.0002140227,0.001764884,0.00008378389,0.005285247,0.9596761,0.0002999264,0.01798925,0.00009214795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.5137901,0.0267156,0.4366667,0.001141536,0.0009910531,0.002314985,0.005480208,0.003737227,0.009162544],"genre_scores_gemma":[0.5719846,0.01571333,0.3878748,0.002632699,0.0003277746,0.003881996,0.005155009,0.0003519624,0.01207784],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.001848349,"threshold_uncertainty_score":0.009775162,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379276540","doi":"10.33380/2305-2066-2023-12-2-62-72","title":"Development, Validation and Approbation Analytical Method for the Quantitative Determination of Taurine by HPLC-UV Method in the Test of Comparative Dissolution Kinetics","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Taurine; Chromatography; Chemistry; Dissolution; Derivatization; Kinetics; High-performance liquid chromatography; Dosage form; Amino acid; Biochemistry; Organic chemistry","authors":[{"name":"A. M. Poluyanov","is_ca":false},{"name":"A. Kochug","is_ca":true},{"name":"L. S. Mitrofanova","is_ca":true},{"name":"I. D. Nikitin","is_ca":false},{"name":"O. Yu. Vergasov","is_ca":false},{"name":"I. E. Shohin","is_ca":true},{"name":"Е. Н. Фишер","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04815994886209583,"gpt":0.372205494514972,"spread":0.3240455456528761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006177739,0.001863539,0.001329866,0.002659715,0.001281197,0.001360054,0.001635391,0.00301834,0.004770466],"category_scores_gemma":[0.007514421,0.001002262,0.001333018,0.00109979,0.001439803,0.001003463,0.001069078,0.001795081,0.003769629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001043987,"about_ca_system_score_gemma":0.003067359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001390827,"about_ca_topic_score_gemma":0.001889624,"domain_scores_codex":[0.9846,0.002904121,0.001015052,0.002426173,0.008693523,0.0003611339],"domain_scores_gemma":[0.994787,0.000821861,0.0006880485,0.0006432447,0.002862554,0.0001972069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009601468,0.0007097093,0.004880375,0.001600649,0.0001979543,0.0003784098,0.0003275384,0.0007094792,0.8795378,0.001080149,0.002692102,0.1069256],"study_design_scores_gemma":[0.0001902351,0.002322843,0.01105044,0.0003078229,0.0003749416,0.002156949,0.0001631907,0.006057759,0.9299338,0.0003125569,0.04695388,0.0001755875],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.2028756,0.02397665,0.7271046,0.001258232,0.002336475,0.00833728,0.002625814,0.006602505,0.02488294],"genre_scores_gemma":[0.3135895,0.007726464,0.6425214,0.001270906,0.0004623093,0.00625169,0.003351069,0.00066745,0.02415912],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.006177739,"threshold_uncertainty_score":0.03267139,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379276580","doi":"10.33380/2305-2066-2023-12-2-190-197","title":"Development and Validation of the ELISA Method for Neutralizing Anti-trastuzumab Antibodies Detection in Human Blood Serum","year":2023,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Trastuzumab; Medicine; Immunogenicity; Antibody; Bioequivalence; Gold standard (test); Pharmacology; Cancer; Immunology; Internal medicine; Breast cancer; Pharmacokinetics","authors":[{"name":"М. А. Колганова","is_ca":false},{"name":"Olesya Sagimbaeva","is_ca":false},{"name":"Ju. S. Borisova","is_ca":false},{"name":"Е. Е. Бекетов","is_ca":false},{"name":"И. Е. Шохин","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04488240243248364,"gpt":0.3468475382783933,"spread":0.3019651358459096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005498412,0.00118915,0.000741912,0.002082404,0.0006052586,0.001031134,0.001069549,0.00231215,0.001227408],"category_scores_gemma":[0.006800693,0.0007285255,0.001091796,0.0008284458,0.0008877419,0.0005928868,0.0008079965,0.001560288,0.001255768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007509482,"about_ca_system_score_gemma":0.001696691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001265925,"about_ca_topic_score_gemma":0.001939638,"domain_scores_codex":[0.98906,0.002915937,0.0006231543,0.001623481,0.005437273,0.0003400571],"domain_scores_gemma":[0.9971201,0.0007049908,0.0003890592,0.0002297499,0.001456687,0.00009942522],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003360242,0.000474983,0.004468739,0.0006828321,0.0001067457,0.0002132279,0.0002725603,0.000961373,0.9517735,0.0008609662,0.0007527546,0.03909615],"study_design_scores_gemma":[0.00007269027,0.001655126,0.007039939,0.0001738585,0.0001498442,0.001537793,0.0001404467,0.01002651,0.9647639,0.0003674783,0.01397884,0.00009352496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.331896,0.01794367,0.6309447,0.00119214,0.001084175,0.002827952,0.001428467,0.001972945,0.01070992],"genre_scores_gemma":[0.5054742,0.007312467,0.4703952,0.00122263,0.0002335907,0.002602444,0.002014052,0.000153084,0.01059241],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.005498412,"threshold_uncertainty_score":0.02907872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2971404000","doi":"10.33380//2305-2066-2019-8-3-91-100","title":"A Comparative Parallel Study of Pharmacokinetics and Immunogenicity Following Single Intravenous Administration of Bevacizumab Biosimilar RPH-001 (Manufactured by R-Pharm Group, Russia) and Avastin® (Manufactured by F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Male Volunteers","year":2019,"lang":"en","type":"article","venue":"Drug development & registration","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Public Health Association","funders":"","keywords":"Bevacizumab; Medicine; Pharmacokinetics; Immunogenicity; Biosimilar; Pharmacology; Antibody; Internal medicine; Immunology; Chemotherapy","authors":[{"name":"М. А. Колганова","is_ca":true},{"name":"N. S. Bagaevа","is_ca":true},{"name":"Y. V. Medvedev","is_ca":false},{"name":"I. E. Shohin","is_ca":true},{"name":"A. V. Demchinskaya","is_ca":false},{"name":"Т. Н. Палкина","is_ca":false},{"name":"D. A. Salazanov","is_ca":false},{"name":"G. E. Konopleva","is_ca":false},{"name":"M. S. Sheremeteva","is_ca":false},{"name":"Sh. Z. Archuadze","is_ca":false},{"name":"Ya. V. Lavrovsky","is_ca":false},{"name":"А. Yu. Savchenko","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01506334516909279,"gpt":0.2746510225225968,"spread":0.259587677353504,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001347555,0.0006724509,0.0007504431,0.0002601252,0.000246897,0.0003590712,0.0002503808,0.0005629199,0.001746123],"category_scores_gemma":[0.001512359,0.0003709172,0.0005536925,0.0001842518,0.0006338551,0.0003765559,0.0002374656,0.0007141604,0.000556828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002225604,"about_ca_system_score_gemma":0.0003458368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002168751,"about_ca_topic_score_gemma":0.0001421068,"domain_scores_codex":[0.9993461,0.0002026084,0.00003789184,0.0002183097,0.0001317671,0.00006333791],"domain_scores_gemma":[0.9989617,0.0002174185,0.0002054327,0.000210428,0.0001654651,0.0002396437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4444961,0.08323894,0.02596738,0.0006351028,0.0006756441,0.0004422666,0.001123084,0.001077812,0.3712495,0.0003600553,0.0008447565,0.06988939],"study_design_scores_gemma":[0.01572825,0.8476996,0.0862456,0.00001483196,0.0005696688,0.0008070385,0.0001218004,0.001669713,0.0443714,0.0002311172,0.002490837,0.00005014164],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981602,0.0002427159,0.0007291213,0.00001403866,0.00003820739,0.000353379,0.000123308,0.00001457462,0.0003244449],"genre_scores_gemma":[0.9960211,0.00024215,0.001294269,0.00008504774,0.0001011115,0.0006150238,0.0004957236,0.00001357075,0.001131866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001746123,"threshold_uncertainty_score":0.007126629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}